Kensler, T W <br/><br/>
Therapeutic effects of acivicin and N-(phosphonacetyl)-L-aspartic acid in a biochemically designed trial against a N-(phosphonacetyl)-L-aspartic acid-resistant variant of the Lewis lung carcinoma.  [electronic resource] 

 -  Cancer research  Mar 1981 
 - 905-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aspartate Carbamoyltransferase--antagonists & inhibitors<br/>Aspartic Acid--administration & dosage<br/>Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing)--antagonists & inhibitors<br/>Carcinoma--drug therapy<br/>Drug Therapy, Combination<br/>Glycine--administration & dosage<br/>Isoxazoles--administration & dosage<br/>Ligases--antagonists & inhibitors<br/>Lung Neoplasms--drug therapy<br/>Neoplasms, Experimental--drug therapy<br/>Organophosphorus Compounds--administration & dosage<br/>Oxazoles--administration & dosage<br/>Phosphonoacetic Acid--administration & dosage<br/>Pyrimidines--biosynthesis<br/>Rats